Archive for the 'MESOMARK' Category

MESOMARK news feed.

Fujirebio Diagnostics Honored with Pioneer Award from Meso Foundation: MESOMARK® Test Recognized for Monitoring Patients with Asbestos-linked Cancer

Malvern, PA – Noting a steadfast dedication and contribution to researching mesothelioma, an asbestos-linked cancer, the Meso Foundation recently bestowed a Pioneer Award to Fujirebio Diagnostics. The company, whose MESOMARK® test was introduced earlier this year, was presented with the award at the Meso Foundation’s annual International Symposium on Malignant Mesothelioma. MESOMARK is the world’s

more

CISBIO Announces FDA Approval of MESOMARK®; Assay Now Available to Physicians in the U.S. for Monitoring Patients with Mesothelioma

CISBIO, a developer and marketer of diagnostic assays for the quantification of tumor markers, announced that the MESOMARK® Assay, the world’s first in vitro test for managing patients with mesothelioma, an aggressive and deadly form of cancer, has been approved by the United States Food and Drug Administration (FDA). The MESOMARK® test is developed and

more

NYU Study Validates Use Of Fujirebio Diagnostics’ MESOMARK Test For Monitoring An Asbestos-Linked Cancer

There is new hope for the thousands of Americans suffering from mesothelioma, an aggressive form of cancer linked to asbestos exposure. Results from a recent study conducted by researchers at New York University (NYU) School of Medicine show the MESOMARK Assay, the world’s first and only in vitro test for monitoring mesothelioma developed by Fujirebio

more

NYU Study Validates Use of the Fujirebio Diagnostics MESOMARK® Test for Monitoring an Asbestos-Linked Cancer

There is new hope for the thousands of Americans suffering from mesothelioma, an aggressive form of cancer linked to asbestos exposure. Results from a recent study conducted by researchers at New York University (NYU) School of Medicine1 show the MESOMARK® Assay, the world’s first and only in vitro test for monitoring mesothelioma developed by Fujirebio

more

Fujirebio Diagnostics Receives FDA Approval for the MESOMARK® Assay for the Management of Mesothelioma Patients

Fujirebio Diagnostics, Inc. (FDI) received approval from the Food & Drug Administration (FDA) under the Humanitarian Device Exemption (HDE) program for the MESOMARK® Assay, the world’s first in-vitro test for mesothelioma, a form of cancer linked to asbestos exposure. Via a simple blood test, the MESOMARK test enables doctors to monitor patients diagnosed with biphasic

more

Ground-Breaking Mesothelioma Detection Study Begins – Libby, MT Residents Participating in Mesothelioma Applied Research Foundation (MARF) Funded Research into Mesothelioma Serum Marker

Exciting new developments using a blood serum marker to detect cancer are being investigated in a longitudinal study in Libby, Montana. In a generous and caring humanitarian act, nearly half of Libby, Montana residents, many of whom have been exposed to asbestos, have agreed to participate in a long term study to calibrate a newly

more

Fujirebio Diagnostics Expands Commercial Availability of First Blood Test for Mesothelioma: Announces Distribution Agreement with Cisbio international to Bring MESOMARK™ to Europe

Fujirebio Diagnostics, Inc. (FDI), a world-leader in oncology testing, and Cisbio international, a French biotechnology company, today announced a distribution agreement for European distribution of FDI’s new blood test for mesothelioma – MESOMARK™. This agreement, the second for FDI, continues the worldwide commercial rollout of MESOMARK. Earlier this year, FDI launched MESOMARK in Australia where

more

Fujirebio Diagnostics Launches First Blood Test for Mesothelioma: Vital Diagnostics to Make Test Commercially Available in Australia

Fujirebio Diagnostics, Inc. (FDI), a world-leader in oncology testing, today announced that it has signed a distributor agreement with Australian-based Vital Diagnostics for its new blood test for mesothelioma – MESOMARK TM. The agreement marks the beginning of the company’s commercial roll-out of MESOMARK, which is now available for the first time in Australia. "The

more

Last update: April 01, 2019. 03:30:08 pm.